Sartorius (SARTF) reported that its underlying EBITDA decreased by 13.8 percent to 234 million euros in the first three months due to lower sales revenue. The resulting margin was 28.
The biotechnology supplier Sartorius has started the new year with declines in sales and profits. Customers are continuing to reduce their inventories. However, the process is at an advanced stage in.
Sartorius Stedim Biotech SA: Resolutions of the Annual Shareholders Meeting of Sartorius Stedim Biotech S A finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
At today s combined Annual Shareholders Meeting of Sartorius Stedim Biotech S.A., shareholders have granted discharge to all directors by a large majority and approved the renewal of the.